We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Fevertree Drinks Plc | FEVR | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -4.00 | -0.45% | 890.00 | 16:35:05 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 860.00 | 860.00 | 899.00 | 890.00 | 894.00 |
| Industry Sector |
|---|
| BEVERAGES |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 25/03/2025 | Final | GBP | 0.1112 | 15/05/2025 | 16/05/2025 | 20/06/2025 |
| 12/09/2024 | Interim | GBP | 0.0585 | 26/09/2024 | 27/09/2024 | 18/10/2024 |
| 26/03/2024 | Final | GBP | 0.109 | 16/05/2024 | 17/05/2024 | 21/06/2024 |
| 12/09/2023 | Interim | GBP | 0.0574 | 28/09/2023 | 29/09/2023 | 20/10/2023 |
| 22/03/2023 | Final | GBP | 0.1068 | 20/04/2023 | 21/04/2023 | 02/06/2023 |
| 13/09/2022 | Interim | GBP | 0.0563 | 29/09/2022 | 30/09/2022 | 21/10/2022 |
| 16/03/2022 | Final | GBP | 0.1047 | 07/04/2022 | 08/04/2022 | 27/05/2022 |
| 16/03/2022 | Special | GBP | 0.429 | 07/04/2022 | 08/04/2022 | 27/05/2022 |
| 15/09/2021 | Interim | GBP | 0.0552 | 30/09/2021 | 01/10/2021 | 22/10/2021 |
| 18/03/2021 | Final | GBP | 0.1027 | 08/04/2021 | 09/04/2021 | 28/05/2021 |
| 08/09/2020 | Interim | GBP | 0.0541 | 24/09/2020 | 25/09/2020 | 16/10/2020 |
| Top Posts |
|---|
Posted at 20/4/2025 09:18 by apad EBITDAMargin 14% ROA 6% ROE 10% OpMargin 9% But: PER 38 Yield 2% Backward facing data but it shows that FEVR is not cheap for its performance figures and what the new US deal is promising. FEVR is my second biggest holding. I am tempted to increase but sitting on my hands for a while. apad |
Posted at 19/4/2025 12:16 by disc0dave46 Hi CT,Good point, believe it's now October not this month when it comes into force. Read one business saying it could increase costs by about 5p per 330ml bottle, say roughly 5%?. In their (FEVR) FY22 with glass costs increasing 10% it did have a bad year but there was other issues associated with energy costs, freight costs etc, so difficult to know given there's not much detail on how much of their income is from glass contained products, they also do cans. I noted that previous posting mentioned Encirc glass serving Molson Coors, which they do but they don't have any manufacturing facilities in the US, they are based in Northern Ireland. So there could be tariff issues as well as the forthcoming glass tax hitting costs as well - don't know the contractual relationship between Molson Coors but could simply decide to acquire their glass requirements from a US manufacturer instead thus I imagine mitigating tariff and glass tax costs. The glass tax in itself is IMO a farce, the tax ends up being higher for glass than plastics due to weight despite the fact glass is a lot easier to recycle - knowing this government's habit of U turns then wouldn't be surprised if it's kicked further down the road. |
Posted at 04/2/2025 09:23 by apad CT I appreciate your posts and insight.My contrary view on this post is based on brand value. Marketing values a brand but this value is not shown on the balance sheet. In the US FEVR are excelling at rollout of new mixers and liaisons with liquor manufacturers. That is their basis for future growth, not manufacture and distribution. apad |
Posted at 30/1/2025 09:48 by martywidget Sizzling Smoky flavour, shorts:Disclosed short positions in Fevertree Drinks (FEVR) Fund % short change Date changed Connor, Clark & Lunn Investment Management Ltd 0.50% 0.0% 6 Dec 2024 JPMorgan Asset Management (UK) Ltd 0.95% -0.05% 16 Dec 2024 Total 1.45% |
Posted at 30/1/2025 07:56 by aishah @sweetstocksblogFevertree's Molson Coors deal looks poor * issuing shares at lowest price in 10yrs, not the long-hoped-for big premium * FEVR itself paying upfront towards extra marketing * big profit warning for 2025, with jam from 2027 on? Was no better deal on offer? |
Posted at 30/1/2025 07:53 by bulltradept Good to see, quite a decent thing for FEVR Mgt to do. |
Posted at 04/12/2024 13:55 by wetdream Nick Train ‘in pain’ over Diageo bet and fund performancePresumably FEVR contributing to his ‘pain’. |
Posted at 02/12/2024 09:14 by castleford tiger ValueHurtsNot in the first half results they were flat. last full year sales were up 20m to 364m which........ is LESS THAN HALF MARKET CAP net profit fell £10m giving a p/e of 50+ I do understand that FEVR has never looked a sensible valuation. The big concern is the UK sales are falling. Tiger |
Posted at 13/9/2024 09:19 by masurenguy Fever-Tree commits to London listing as shares hit 8 year lowA dismal start to the British summer takes shine off sales at the mixers group Announcing first-half results, the company lowered expectations for annual revenue growth to 4-5%, from a previously guided 10% in March. Fever-Tree also cut its 2023 annual forecast at the same stage last year by 15% and took a £3.3m hit on its US division from a production issue. The update sent shares in Fever-Tree down by 100p, or 11.6%, to an eight-year low at 762½p on the Aim index. The stock remains well below the highs of almost £40 achieved before the pandemic and cost-of-living crisis shuttered pubs and wallets. In the first half, Fever-Tree reported a 2% increase in revenue to £170.6m, with the UK down 6% to £50.9 million and Europe down 12% to £44.5m. The US was up 7 per cent to £60.3m, and revenues for the rest of the world were 57% higher at £14.9m. Underlying earnings in the first half jumped by 79% to £18.2m, and the company declared a dividend up 2% at 5.85p per share. Warrillow, 49, who remains chief executive, said that the situation had improved strongly “as summer belatedly arrived. Whilst the first half was challenging, we are controlling the controllables. We’re optimistic of an acceleration of growth across the second half of the year and have seen a much more positive trading performance in July and August.” “Fevertree is doing the right things, gaining share and delivering on gross margin recovery, in a difficult market,” Investec analyst Matthew Webb said. Complete article: No position but onto my watchlist. |
Posted at 13/9/2024 07:25 by laurence llewelyn binliner An interesting watch, I am looking to replace BVIC now bought out by Carlsberg, could FEVR become the next target for a bigger player and more MnA..? 10% off yesterday and could continue south with the revised outlook..? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
